[1]
M. Hazra, “A comparative study on the pharmacovigilance scoring of causality assessment grading and staging of topical pharmacotherapy of ofloxacin 0.3% ophthalmic solution in bacterial conjunctivitis and ofloxacin 0.3% otic solution in otitis externa”, Int J Basic Clin Pharmacol, vol. 11, no. 2, pp. 173–180, Feb. 2022.